Antithrombotics drugs in Gastrointestinal Endoscopy. Position Statment of the Catalan Society of Gastroenterology.

Introduction: The use of antiplatelet and anticoagulant drugs is common in patients undergoing elective endoscopic procedures. To minimize both bleeding and thromboembolic risks, an individualized assessment is essential. For this purpose, the Societat Catalana de Digestologia (SCD) commissioned a consensus document aimed at providing practical recommendations based on the best available evidence and expert agreement.

Material and methods: A panel of 10 specialists from the fields of Gastroenterology, Cardiology, Hematology, and Anesthesiology were involved in the development of the document. A non-systematic review of the literature was conducted using a modified Delphi method through online voting. Recommendations were reviewed and discussed during each round until consensus was reached. Recommendations with ≥80% agreement were accepted.

Results: A total of 16 endoscopic procedures were assessed based on their hemorrhagic risk, and tailored management guidelines were defined to different groups of antithrombotic agents. The document includes a management algorithm and stratification tables for bleeding and thrombotic risk.

Conclusion: The recommendations developed by the SCD integrate international evidence and are adapted to the local healthcare context, providing a valuable tool for clinical practice. The importance of multidisciplinary coordination and effective communication with the patient is emphasized to ensure safety throughout the periprocedural period.